| Dr John S Cullen, MD | |
|
1001 Meals Ave., Valdez, AK 99686 | |
| (907) 835-4811 | |
| (907) 835-5162 |
| Full Name | Dr John S Cullen |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 1001 Meals Ave., Valdez, Alaska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881781185 | NPI | - | NPPES |
| MD14902 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3426 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Valdez Medical Center | Valdez, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Of Valdez | 3577514694 | 13 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 7 days ago
| Entity Name | Valdez Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255428512 PECOS PAC ID: 0648251579 Enrollment ID: O20040526001616 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 7 days ago
| Entity Name | City Of Valdez |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1750485488 PECOS PAC ID: 3577514694 Enrollment ID: O20061104000452 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 7 days ago
| Entity Name | City Of Valdez |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427424282 PECOS PAC ID: 3577514694 Enrollment ID: O20160406001911 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John S Cullen, MD Po Box 1829, Valdez, AK 99686-1829 Ph: (907) 835-4811 | Dr John S Cullen, MD 1001 Meals Ave., Valdez, AK 99686 Ph: (907) 835-4811 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.
Cancer diagnostics company Biomoda, Inc. filed an application for a new U.S. Patent that refines the use of fluorescent microscopy to increase the accuracy, sensitivity and specificity of the CyPath diagnostic assay for lung cancer.
› Verified 7 days ago
Corina Hopkins-vacca, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 Meals Avenue, Valdez, AK 99686 Phone: 907-835-2249 Fax: 907-834-1890 | |
Dr. Kathleen G Todd, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1001 Meals Avenue, Valdez, AK 99686 Phone: 907-835-4811 Fax: 907-835-5162 | |
Dr. Angela D Alfaro, MD, MS Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 154 Fairbanks Drive, Valdez, AK 99686 Phone: 907-835-2532 Fax: 907-835-2362 |